Abstract
The relationship between herpes simplex virus (HSV) and oral mucositis was investigated in children undergoing antineoplastic chemotherapy. HSV culture was performed in 20 children with stomatitis developing after antineoplastic chemotherapy. Viral isolates were typed and susceptibility to acyclovir was investigated. The virus was isolated from oral lesions in 10 of 20 children with severe oral mucositis. Viral reactivation was the most likely explanation in most cases, since HSV was isolated in 9 of 13 seropositive patients (and in 1 patient with unknown anti-HSV serology), but in no seronegative patient. HSV type 1 was isolated more frequently than HSV type 2 (8 versus 2). Acyclovir showed standard in vitro activity against all isolates. Our results suggest that oral mucositis in children receiving antineoplastic treatment is probably multifactorial in origin and that HSV can be an important cofactor, especially in children who are seropositive for HSV. In our Centre, acyclovir remains active in vitro against this opportunistic pathogen and could be employed in prophylaxis and therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Awada A, Van der Auwera P, Meunier F, Daneau D, Klastersky J (1992) Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Disa 15:33–48
Barret AP (1987) A long-term prospective clinical study of oral complications during conventional chemotherapy for acute leukemia. Oral Surg Oral Med Oral Pathol 63:313–316
Beattie G, Whelan J, Cassidy J, Milne L, Burns S, Leonard R (1989) Herpes simplex virus, Candida albicans and mouth ulcers in neutropenic patients with non-haematological malignancy. Cancer Chemother Pharmacol 25:75–76
Bergmann OJ, Mogensen SC, Mogensen SC, Ellegaard J (1990) Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies. Eur J Clin Microbiol Infect Dis 9:184–190
Cooper PD (1967) The plaque assay of animal viruses. In: Maramorsch K, Koprowski H (eds) Methods in virology Academic Press New York, pp 243–305
Corey L, Spear PG (1986) Infections with herpes simplex viruses. N Engl J Med 106:686–691
Dreizen S, McCredie KB, Bodey GP, Keating MJ (1986) Quantitative analysis of the oral complications of antileukemia chemotherapy. Oral Surg Oral Med Oral Pathol 62:650–653
Greenberg MS, Friedman H, Cohen SG, Oh SH, Laster L, Starr S (1987) A comparative study of herpes simplex infections in renal transplant and leukemia patients. J Infect Dis 156:280–287
Hansen HH, Salawry OS, Holland JF, McCall CB (1979) The variability of individual tolerance to methotrexate in cancer patients. Br J Cancer 25:298–305
Hirsch MS (1988) Herpes group virus infections in the compromised host. In: Rubin RH, Young LS (eds) Clinical approach to infection in the compromised host. Plenum Press, New York, pp 347–366
Janmohamed R, Morton JE, Milligan DW, Leyland MJ, Coupland B (1990) Herpes simplex in oral ulcers in neutropenic patients. Br J Cancer 61:469–470
Kisner DL (1988) Reporting treatment toxicities. In: Buyse ME, Staquet MJ, Sylvester RJ (eds) Cancer clinical trials. Methods and practice. Oxford Medical Publications, Oxford, pp 178–190
Kost RG, Hill EL, Tigger M, Straus SE (1993) Brief report: acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med 329:1777–1782
Lam MT, Pazin GJ, Armstrong JA, Ho M (1981) Herpes simplex infections in acute myelogenous leukaemia and other haematological malignancies: a prospective study. Cancer 48:2168
Lockhart PB, Sonis ST (1981) Alterations in the oral mucosa caused by chemotherapeutic agents: a histologic study. J Dermatol Surg Oncol 7:1019–1025
McLaren C, Correy L, Dekker C, Barry DW (1983) A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses from acyclovir-treated patients. J Infect Dis 148:868–875
Mel'nichenko EM (1983) Recurrent herpetic stomatitis in a child with leukemia. Stomatologia (Mosk) 62:74–75
Meyers JD, Flournoy N, Thomas ED (1980) Infection with herpes simplex virus and cell-mediated immunity after bone-marrow transplant. J Infect Dis 142:338–346
Parris DS, Harrington JE (1982) Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates. Antimicrob Agents Chemother 22:71–77
Rand KH, Kramer B, Johnson AC (1982) Cancer chemotherapy associated symptomatic stomatitis. Role of herpes simplex virus (HSV). Cancer 50:1262–1265
Rawls WE (1985) Herpes simplex virus. In: Lennette EM (ed) Laboratory diagnosis of viral infection. Dekker, New York, p 316
Ringden O, Heimdahl A, Lonnqvist B, Malmborg AS, Wilczek H (1984) Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir. Lancet 1:744
Svennerholm B, Vahline A, Lowhagen GB, Widell A, Lycke E (1985) Sensitivity of HSV strains isolated before and after treatment with acyclovir. Scand J Infect Dis Suppl 310:1551–1556
Wade JC, McLaren C, Meyer JD (1993) Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J Infect Dis 148:1077–1081
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carrega, G., Castagnola, E., Canessa, A. et al. Herpes simplex virus and oral mucositis in children with cancer. Support Care Cancer 2, 266–269 (1994). https://doi.org/10.1007/BF00365734
Issue Date:
DOI: https://doi.org/10.1007/BF00365734